A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Impax Asset Management 09 Jan 2023

AUM up 6% in Q1 of FY23, in line with forecasts

Impax has recorded a strong Q1 of FY23, with AUM growing by £2.3bn (+6.4%), from £35.7bn on 30 Sep...

Read more
Mattioli Woods 05 Jan 2023

On track to meet forecasts, positive outlook

Mattioli Woods (MW) has reported H1-23 revenue (to 30 Nov 22) of £54.9m, 10% up y-o-y (H1-22:...

Read more
Kinarus AG 03 Jan 2023

Implications of recent news flow

The recent news flow on Kinarus’ lead product KIN001 has bolstered its profile for the treatment of...

Read more
Destiny Pharma 22 Dec 2022

Positive update on partner deals

Destiny have announced a trading update that includes a bolus of progress on the partnering of its...

Read more
Marshall of Cambridge 19 Dec 2022

Record results sets up the future

MCH delivered record results, largely due to an exceptional performance from Marshall Motor...

Read more
Cohort 15 Dec 2022

Record closing order book

For the six months to 31 October 2022, Cohort PLC reported a strong performance: revenue was up...

Read more
Begbies Traynor 13 Dec 2022

Resilient income streams drive H1 result

Another strong half reflects the benefits of an increasingly diverse base of cyclical and...

Read more
RUA Life Sciences 12 Dec 2022

Messages from the interim results

RUA Life Sciences’ interim results include in-depth updates on the development of its vascular...

Read more
Benchmark Holdings 07 Dec 2022

FY22 results deliver sustainable growth

For the year to 30 September 2022, Benchmark Holdings reported revenue of £158.3m, +27%YoY and...

Read more
Destiny Pharma 05 Dec 2022

Validation for microbiomes

With the first ever FDA approval for a faecal microbiome drug the door has been opened for other...

Read more

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates